Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19
COVID-19에 걸린 회복기 환자에서 유도된 항체에 의한 중화에 대한 SARS-CoV-2 변이체의 내성
Article
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Anti-spike
anti-spike antibody
anti-spike MAbs
antibody
antibody-based therapies
antibody-based therapy
B.1.1.7
B.1.351
Brazil
caused
Cluster
convalescent COVID-19 patient
convalescent patient
Convalescent patients
convalescent plasma
convalescent plasma samples
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
effective
Efficacy
evaluate
FIVE
high affinity
IgG
Immunoglobulin
Impact
Infection
mAb
mAbs
memory B cells
Mutation
neutralization
Neutralizing
neutralizing activities
Neutralizing antibodies
neutralizing antibody
neutralizing monoclonal antibodies
neutralizing monoclonal antibody
P.1
patients
Rapid
Receptor-binding domain
resistance
respiratory
robust
SARS-CoV-2
SARS-CoV-2 variant
SARS-CoV-2 variants
severe acute respiratory syndrome Coronavirus
severe acute respiratory syndrome coronavirus 2
significantly
single-cell
South Africa
Spike protein
Spread
the receptor-binding domain
the spike protein
therapeutic option
Vaccine
variant
variants
with COVID-19
[DOI] 10.1016/j.celrep.2021.109385 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.celrep.2021.109385 PMC 바로가기 [Article Type] Article